New England Private Wealth Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.24M Buy
225,798
+12,591
+6% +$505K 0.89% 37
2026
Q1
$7.71M Buy
213,207
+27,182
+15% +$1.04M 0.89% 35
2025
Q4
$7.15M Buy
186,025
+2,003
+1% +$75.3K 0.89% 38
2025
Q3
$6.66M Buy
184,022
+470
+0.3% +$16.4K 0.88% 36
2025
Q2
$6.33M Buy
183,552
+3,594
+2% +$114K 0.93% 33
2025
Q1
$5.63M Buy
179,958
+12,341
+7% +$403K 0.87% 34
2024
Q4
$5.36M Buy
167,617
+41,408
+33% +$1.35M 0.85% 34
2024
Q3
$4.12M Buy
126,209
+50,960
+68% +$1.6M 0.66% 40
2024
Q2
$2.33M Buy
75,249
+22,200
+42% +$661K 0.41% 50
2024
Q1
$1.57M Buy
53,049
+26,278
+98% +$745K 0.28% 60
2023
Q4
$713K Buy
+26,771
New +$696K 0.13% 84

Other funds holding QLTY

New England Private Wealth Advisors's QLTY Position: Q2 2026 in Review

New England Private Wealth Advisors increased its GMO US Quality ETF (QLTY) stake by 5.9% in Q2 2026, buying an estimated $505K and bringing the position to 225,798 shares worth $9.24M. The position accounts for 0.89% of the portfolio, ranked #37.

New England Private Wealth Advisors first reported a position in QLTY in Q4 2023 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • New England Private Wealth Advisors held 225,798 shares of GMO US Quality ETF worth $9.24M as of Q2 2026.
  • New England Private Wealth Advisors bought 12,591 GMO US Quality ETF shares in Q2 2026, an estimated $505K.
  • GMO US Quality ETF made up 0.89% of New England Private Wealth Advisors's portfolio in Q2 2026, its #37 holding.
  • New England Private Wealth Advisors first reported a position in GMO US Quality ETF in Q4 2023 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on New England Private Wealth Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.